Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2025)

Indivior Pharmaceuticals has reported Net Margin over the past 2 years, most recently at 28.49% for Q4 2025.

  • Quarterly results put Net Margin at 28.49% for Q4 2025, up 2147.0% from a year ago — trailing twelve months through Dec 2025 was 16.94% (up 1635.0% YoY), and the annual figure for FY2025 was 16.95%, up 1636.0%.
  • Net Margin for Q4 2025 was 28.49% at Indivior Pharmaceuticals, up from 13.38% in the prior quarter.
  • Over the last five years, Net Margin for INDV hit a ceiling of 28.49% in Q4 2025 and a floor of 32.78% in Q2 2024.